The Edge of Magnetic Resonance

High and ultra-high signal-to-noise performance is a core advantage of advanced high-field scanners compared with lower-field or routine clinical systems. This substantially higher signal quality can be leveraged in several ways: (1) achieving image quality comparable to standard clinical scanners with significantly reduced acquisition times; (2) producing images with enhanced contrast and/or spatial resolution relative to conventional clinical systems, without increasing scan time; or (3) applying tailored trade-offs between scan time reduction and image quality improvement, optimized for each care setting, patient population, and clinical use case.

​

Beyond image performance, this signal-to-noise advantage functions as a platform capability that enables MRI systems to become more compact, easier to deploy, and more cost-effective. Such systems can be purpose-built for targeted applications—such as breast imaging or liver assessment for fatty tissue screening—bringing MRI diagnostics closer to point-of-care environments. This QBoosted Coil is available under RUO label only. 

​

In development:

Real Time Non Invasive Point of Care Diagnostics

Next-Generation QBoosted™ MRI RF Coil
Our next-generation QBoosted™ MRI RF Coil is being designed to enable both high-resolution anatomical MRI and molecular imaging using a single integrated hardware platform. By combining conventional MRI signal acquisition with quantum-enhanced sensing capabilities, the coil aims to provide co-registered structural and molecular information in the same imaging session, eliminating the need for separate imaging systems or hardware changes. This unified approach has the potential to improve workflow efficiency, enhance diagnostic confidence, and open new possibilities for non-invasive visualization of tissue structure alongside underlying molecular and metabolic activity.

Point of Care Blood Analysis
gSpin is pioneering a new generation of blood diagnostics with a non-invasive, contactless tabletop device designed to deliver real-time metabolic insights—without the need for blood draws. Powered by quantum-enhanced sensing, the system is being developed to enable fast, on-the-spot health assessments and support more informed clinical decision-making wherever care is delivered.

By removing the barriers of venipuncture, gSpin’s approach has the potential to improve patient comfort and engagement, broaden access to screening, and support earlier insight into a wide range of acute and chronic conditions, including metabolic, cardiovascular, and infectious diseases. The device is currently under development.